|Bid||0.00 x 800|
|Ask||0.00 x 1100|
|Day's Range||201.93 - 206.91|
|52 Week Range||139.59 - 336.99|
|Beta (5Y Monthly)||1.41|
|PE Ratio (TTM)||19.12|
|Earnings Date||Nov. 01, 2021 - Nov. 05, 2021|
|Forward Dividend & Yield||5.68 (2.86%)|
|Ex-Dividend Date||Sep. 20, 2021|
|1y Target Est||363.33|
With its stock down 30% over the past three months, it is easy to disregard Medifast (NYSE:MED). But if you pay close...
Medifast (MED) has long been gaining on the strength of its OPTAVIA lifestyle solution and coaching support system, while rising SG&A costs are a worry.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.